Evidence map›Paper›PMID 31720022›Full record

ArticleActa naturae

A Unique Prototypic Device for Radiation Therapy: The p53-Independent Antiproliferative Effect of Neutron Radiation.

D I Yurkov, S V Syromukov, V V Tatarskiy, E S Ivanova, A I Khamidullina, M A Yastrebova, V I Sysoev, R V Dobrov, A V Belousov, V N Morozov and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

D I YurkovN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
S V SyromukovN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
V V TatarskiyBlokhin National Medical Center of Oncology, Kashirskoye Sh. 24, Moscow, 115478, Russia.
E S IvanovaBlokhin National Medical Center of Oncology, Kashirskoye Sh. 24, Moscow, 115478, Russia.
A I KhamidullinaInstitute of Gene Biology, Russian Academy of Sciences, Vavilova Str. 34/5, Moscow, 119334, Russia.
M A YastrebovaInstitute of Gene Biology, Russian Academy of Sciences, Vavilova Str. 34/5, Moscow, 119334, Russia.
V I SysoevN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
R V DobrovN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
A V BelousovA.I. Burnasyan Federal Medical Biophysical Center, Marshala Novikova Str. 23, Moscow, 123098, Russia.
V N MorozovN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
M A KolyvanovaA.I. Burnasyan Federal Medical Biophysical Center, Marshala Novikova Str. 23, Moscow, 123098, Russia.
G A KrusanovA.I. Burnasyan Federal Medical Biophysical Center, Marshala Novikova Str. 23, Moscow, 123098, Russia.
V I ZverevN.L. Dukhov All-Russia Research Institute of Automatics, Sushchevskaya Str. 22, Moscow, 127055 , Russia.
A A ShtilBlokhin National Medical Center of Oncology, Kashirskoye Sh. 24, Moscow, 115478, Russia.
All Russia Research Institute of Automatics · RUInstitute of Gene Biology · RUNational Medical Center · KRState Scientific Center of the Russian Federation - Federal Medical Biophysical Center named after A.I. Burnazyan · RULomonosov Moscow State University · RURussian Cancer Research Center NN Blokhin · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy with heavy particles including neutrons, an otherwise therapeutically perspective because of its high tissue penetration and efficient tumor damage, is currently limited by the lack of adequate equipment. An NG-24 generator (140 kg, 42 × 110 cm, ~1011 particles/s, > 14 MeV) has been designed and engineered to replace the huge and environmentally harmful neutron reactors, cyclotrons, and accelerators with a compact, portable, safe, and potent source of high-energy neutrons. We demonstrate that the neutron beam produced by NG-24 causes a significant antiproliferative effect on human tumor cell lines regardless of the status of the anti-apoptotic p53 protein. Phosphorylation of histone 2A and increased amounts of p21, cyclin D, and phospho-p53 were detectable in HCT116 colon carcinoma cells (wild-type p53) irradiated with 4 Gy several days post-treatment, accompanied by G2/M phase arrest. These treatments dramatically reduced the ability of single cells to form colonies. In the HCT116p53KO subline (p53 -/-), the G2/M arrest was independent of the aforementioned mechanisms. Hence, the NG-24 generator is a source of a powerful, therapeutically relevant neutron flux that triggers a p53-independent antiproliferative response in tumor cells.

Indexed as

cell deathDNA damagefast neutronsneutron generatorstumor cells

Identifiers

PMID31720022
PMCPMC6826147
OpenAlexW2982312364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.